Dr Reddy's Q4 profit falls 86% YoY to ₹221 crore
pre-market1 source ↓written by the desknot a recommendation
- ₹221 crore
- 86% YoY
- ₹1,587 crore
- Revenue declined
- 12%
- compared
- ₹7,516 crore
Dr. Reddy's Laboratories reported a consolidated net profit of ₹221 crore, down 86% YoY from ₹1,587 crore. Revenue declined 12% to ₹7,516 crore compared to ₹8,506 crore last year. The board proposed a final dividend of ₹8 per share, subject to shareholder approval. 📉
Not investment advice. For informational purposes only.